Cibc Private Wealth Group, LLC Harmony Biosciences Holdings, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,310 shares of HRMY stock, worth $97,082. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,310
Previous 4,214
21.45%
Holding current value
$97,082
Previous $145,000
24.83%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HRMY
# of Institutions
291Shares Held
46.2MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$194 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$171 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$150 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$47.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$46.4 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.74B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...